vs
Acadia Healthcare Company, Inc.（ACHC）とExlService Holdings, Inc.（EXLS）の財務データ比較。上の社名をクリックして会社を切り替えられます
Acadia Healthcare Company, Inc.の直近四半期売上が大きい（$829.0M vs $542.6M、ExlService Holdings, Inc.の約1.5倍）。ExlService Holdings, Inc.の純利益率が高く（11.1% vs 0.5%、差は10.6%）。ExlService Holdings, Inc.の前年同期比売上増加率が高い（12.7% vs 7.5%）。過去8四半期でExlService Holdings, Inc.の売上複合成長率が高い（11.5% vs 2.0%）
アカディア・ヘルスケアはアメリカ合衆国に本拠を置く営利目的の行動医療サービス提供企業です。現在アメリカ本土とプエルトリコにわたり225カ所以上の医療施設を運営し、広範な行動ヘルスケアネットワークを構築して、専門的なサービスを提供しています。
ExlService Holdings Inc.は保険、ヘルスケア、銀行・金融サービス、メディア、小売などの業界を対象に分析・デジタルソリューションを提供するグローバル企業で、本社はニューヨークに所在し、米国、欧州、アジア、中南米、オーストラリア、南アフリカなど世界各地に5万4000人以上の専門スタッフを擁しています。
ACHC vs EXLS — 直接比較
損益計算書 — Q1 FY2026 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $829.0M | $542.6M |
| 純利益 | $4.5M | $60.2M |
| 粗利率 | — | 38.6% |
| 営業利益率 | — | 14.4% |
| 純利益率 | 0.5% | 11.1% |
| 売上前年比 | 7.5% | 12.7% |
| 純利益前年比 | -50.8% | 18.9% |
| EPS（希薄化後） | $0.05 | $0.38 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $542.6M | ||
| Q3 25 | $851.6M | $529.6M | ||
| Q2 25 | $869.2M | $514.5M | ||
| Q1 25 | $770.5M | $501.0M | ||
| Q4 24 | $774.2M | $481.4M | ||
| Q3 24 | $815.6M | $472.1M | ||
| Q2 24 | $796.0M | $448.4M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $60.2M | ||
| Q3 25 | $36.2M | $58.2M | ||
| Q2 25 | $30.1M | $66.1M | ||
| Q1 25 | $8.4M | $66.6M | ||
| Q4 24 | $32.6M | $50.7M | ||
| Q3 24 | $68.1M | $53.0M | ||
| Q2 24 | $78.5M | $45.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 38.5% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 38.6% | ||
| Q4 24 | — | 38.1% | ||
| Q3 24 | — | 37.8% | ||
| Q2 24 | — | 37.1% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 14.4% | ||
| Q3 25 | 4.7% | 14.4% | ||
| Q2 25 | 5.8% | 15.8% | ||
| Q1 25 | 1.7% | 15.7% | ||
| Q4 24 | 4.9% | 14.8% | ||
| Q3 24 | 12.1% | 14.7% | ||
| Q2 24 | 13.4% | 13.7% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 11.1% | ||
| Q3 25 | 4.3% | 11.0% | ||
| Q2 25 | 3.5% | 12.8% | ||
| Q1 25 | 1.1% | 13.3% | ||
| Q4 24 | 4.2% | 10.5% | ||
| Q3 24 | 8.4% | 11.2% | ||
| Q2 24 | 9.9% | 10.2% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.38 | ||
| Q3 25 | $0.40 | $0.36 | ||
| Q2 25 | $0.33 | $0.40 | ||
| Q1 25 | $0.09 | $0.40 | ||
| Q4 24 | $0.36 | $0.31 | ||
| Q3 24 | $0.74 | $0.33 | ||
| Q2 24 | $0.85 | $0.28 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $158.5M | $328.4M |
| 総負債低いほど良い | $2.5B | $298.6M |
| 株主資本純資産 | $2.0B | $912.7M |
| 総資産 | $5.5B | $1.7B |
| 負債/資本比率低いほどレバレッジが低い | 1.29× | 0.33× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $328.4M | ||
| Q3 25 | $118.7M | $390.1M | ||
| Q2 25 | $131.4M | $353.3M | ||
| Q1 25 | $91.2M | $331.4M | ||
| Q4 24 | $76.3M | $340.6M | ||
| Q3 24 | $82.1M | $325.8M | ||
| Q2 24 | $77.2M | $276.1M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $298.6M | ||
| Q3 25 | $2.3B | $354.8M | ||
| Q2 25 | $2.3B | $260.0M | ||
| Q1 25 | $2.2B | $307.3M | ||
| Q4 24 | $2.0B | $288.5M | ||
| Q3 24 | $1.9B | $344.7M | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $912.7M | ||
| Q3 25 | $3.1B | $952.4M | ||
| Q2 25 | $3.1B | $1.1B | ||
| Q1 25 | $3.0B | $1.0B | ||
| Q4 24 | $3.1B | $929.9M | ||
| Q3 24 | $3.0B | $907.6M | ||
| Q2 24 | $3.0B | $852.6M |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $1.7B | ||
| Q3 25 | $6.4B | $1.7B | ||
| Q2 25 | $6.3B | $1.7B | ||
| Q1 25 | $6.1B | $1.7B | ||
| Q4 24 | $6.0B | $1.6B | ||
| Q3 24 | $5.9B | $1.6B | ||
| Q2 24 | $5.7B | $1.5B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.33× | ||
| Q3 25 | 0.74× | 0.37× | ||
| Q2 25 | 0.74× | 0.25× | ||
| Q1 25 | 0.72× | 0.30× | ||
| Q4 24 | 0.64× | 0.31× | ||
| Q3 24 | 0.62× | 0.38× | ||
| Q2 24 | 0.62× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $61.5M | $117.4M |
| フリーキャッシュフロー営業CF - 設備投資 | — | $106.5M |
| FCFマージンFCF / 売上 | — | 19.6% |
| 設備投資強度設備投資 / 売上 | — | 2.0% |
| キャッシュ転換率営業CF / 純利益 | 13.78× | 1.95× |
| 直近12ヶ月FCF直近4四半期 | — | $298.1M |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $117.4M | ||
| Q3 25 | $73.2M | $120.7M | ||
| Q2 25 | $133.5M | $109.4M | ||
| Q1 25 | $11.5M | $3.2M | ||
| Q4 24 | $116.7M | $105.3M | ||
| Q3 24 | $163.1M | $110.1M | ||
| Q2 24 | $171.1M | $74.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $106.5M | ||
| Q3 25 | $-63.0M | $106.4M | ||
| Q2 25 | $-34.2M | $95.0M | ||
| Q1 25 | $-163.2M | $-9.7M | ||
| Q4 24 | $-86.8M | $95.3M | ||
| Q3 24 | $-27.1M | $97.3M | ||
| Q2 24 | $16.9M | $62.8M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 19.6% | ||
| Q3 25 | -7.4% | 20.1% | ||
| Q2 25 | -3.9% | 18.5% | ||
| Q1 25 | -21.2% | -1.9% | ||
| Q4 24 | -11.2% | 19.8% | ||
| Q3 24 | -3.3% | 20.6% | ||
| Q2 24 | 2.1% | 14.0% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 2.0% | ||
| Q3 25 | 16.0% | 2.7% | ||
| Q2 25 | 19.3% | 2.8% | ||
| Q1 25 | 22.7% | 2.6% | ||
| Q4 24 | 26.3% | 2.1% | ||
| Q3 24 | 23.3% | 2.7% | ||
| Q2 24 | 19.4% | 2.7% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.95× | ||
| Q3 25 | 2.02× | 2.08× | ||
| Q2 25 | 4.43× | 1.66× | ||
| Q1 25 | 1.37× | 0.05× | ||
| Q4 24 | 3.58× | 2.08× | ||
| Q3 24 | 2.39× | 2.08× | ||
| Q2 24 | 2.18× | 1.63× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
